Clinical Trial Update: Open-Label Study To Evaluate the Safety and Efficacy of the Renal Assist Device In Patients With Acute Renal Failure [Phase 2]

View source ↗

Summary

This update reports results from an open-label Phase 2 trial evaluating the safety and efficacy of the Renal Assist Device in patients with acute kidney injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Renal Assist Device

Snippet

Sponsor: RenaMed Biologics | Conditions: Acute Renal Failure | Phase 2 | Status: COMPLETED